2009
DOI: 10.1016/j.vaccine.2009.09.128
|View full text |Cite
|
Sign up to set email alerts
|

Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 71 publications
0
10
0
1
Order By: Relevance
“…Moreover we could substantiate these findings using whole-cell ELISA experiments similarly demonstrating BamC was surface exposed. In keeping with this finding, BamC (NlpB) has been identified as a prospective vaccine candidate for meningitis, selected in a high-throughput screen for antibodies protecting against Neisseria meningitidis infection 32 . Remarkably, this surface antigen incorporates both helix-grip domains as recognized by cell surface proteolysis.…”
Section: Discussionmentioning
confidence: 90%
“…Moreover we could substantiate these findings using whole-cell ELISA experiments similarly demonstrating BamC was surface exposed. In keeping with this finding, BamC (NlpB) has been identified as a prospective vaccine candidate for meningitis, selected in a high-throughput screen for antibodies protecting against Neisseria meningitidis infection 32 . Remarkably, this surface antigen incorporates both helix-grip domains as recognized by cell surface proteolysis.…”
Section: Discussionmentioning
confidence: 90%
“…More recent bioinformatic approaches used to identify potential novel protein vaccine candidates against serogroup B N. meningitidis have identified several more lipoproteins (NMA1123, -1134, and -1091 [LolB] and NMB0033, -1163, -1946, and -2132 [sometimes NMB is replaced with GNA] [124,137]) that are immunogenic and generate bactericidal antibodies as determined by a serum bactericidal assay. The functions of many of these proteins are unknown, though LolB is recognized by the immune system and was initially identified through early immunological screens of meningococcal libraries with a monoclonal antibody, H.8, that had been developed to selectively recognize pathogenic neisserial strains (31,61).…”
Section: Biological Properties Of Lipoproteins Associated With Virulencementioning
confidence: 99%
“…During the last decade, the availability of meningococcal genome sequence data (Tettelin et al, 2000) has led to the identification of a number of less abundant (minor) cellsurface proteins with vaccine potential (Pajó n et al, 2009;Pizza et al, 2000). The FadL-like protein encoded by the NMB0088 ORF in the MC58 genome is an example and has been identified in meningococcal outer-membrane vesicles prepared from different strains (Uli et al, 2006;Vaughan et al, 2006;Vipond et al, 2006;Williams et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…This has implications for vaccine design: first, the sequence diversity of a meningococcal antigen provides evidence that it is indeed a target of the immune response and, second, it shows that a vaccine formulation containing as little as five protein variants has the potential to offer protection against the majority of hypervirulent lineages. An example of such a vaccine is the developmental NonaMen, which encompasses nine PorA protein types representing the major hypervirulent strains in circulation and should offer protection against the vast majority of invasive disease (van den Dobbelsteen et al, 2007).During the last decade, the availability of meningococcal genome sequence data (Tettelin et al, 2000) has led to the identification of a number of less abundant (minor) cellsurface proteins with vaccine potential (Pajó n et al, 2009;Pizza et al, 2000). The FadL-like protein encoded by the NMB0088 ORF in the MC58 genome is an example and has been identified in meningococcal outer-membrane vesicles prepared from different strains (Uli et al, 2006;Vaughan et al, 2006;Vipond et al, 2006;Williams et al, 2007).…”
mentioning
confidence: 99%